ArticlePloS one2024

Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's disease.

Angela Minnella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.